Pharmaceutical Supply – Sterile Injectable Medication

The contract entails the supply of CEFAZOLIN INJECTION, a sterile antibiotic manufactured and packaged to meet strict FDA, USP, and Department of Defense standards for quality, safety, and regulatory compliance. All packaging and labeling must adhere to federal and military requirements, including accurate identification, lot tracking, and secure chain of custody protocols to ensure the product remains valid and uncontaminated from production through delivery. The medication is intended for use within the Department of Defense healthcare system, necessitating full alignment with defense-specific logistics and distribution procedures. As a subcontract under the Defense Logistics Agency, the work supports critical medical readiness and operational needs across military installations. The NAICS code 325412 confirms the focus on pharmaceutical and medicinal product manufacturing, and the posting date indicates this solicitation is scheduled for future performance beginning in 2026. The contract is governed by stringent quality control measures and must maintain compliance throughout the entire lifecycle, from raw material sourcing to final delivery, with no allowances for deviation from established regulatory and military specifications. Deliveries are subject to inspection and acceptance by DLA, and failure to meet standards may result in rejection or termination.